Surgery: Clinical Studies Open For Enrollment Post-Market Registry in Europe and US for the Use of VascuCel A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial with Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of PROTHROMPLEX TOTAL for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure. Profiling of plasma before and after anticoagulant therapy in patients diagn...